Biogen Inc (BIIB)

Working capital turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	9,675,900	9,607,500	9,672,000	9,663,100	9,835,600	9,993,300	9,971,500	10,104,600	10,173,400	10,363,200	10,633,600	10,819,500	10,981,700	11,100,500	11,697,700	12,604,300	13,444,600	14,263,300	14,487,300	14,422,400
Total current assets	US$ in thousands	7,456,800	6,830,500	7,108,500	6,756,200	6,859,300	8,454,100	10,431,700	9,762,500	9,791,200	9,765,800	9,740,900	7,915,900	7,856,500	7,162,300	7,183,700	6,719,500	6,887,100	7,843,100	8,493,800	8,007,200
Total current liabilities	US$ in thousands	5,528,800	5,425,000	3,108,200	3,222,800	3,434,300	5,022,300	3,186,500	3,014,900	3,272,800	3,926,400	5,018,000	3,946,600	4,298,200	4,211,600	3,347,200	3,165,800	3,742,200	3,804,000	3,447,100	4,638,600
Working capital turnover		5.02	6.84	2.42	2.73	2.87	2.91	1.38	1.50	1.56	1.77	2.25	2.73	3.09	3.76	3.05	3.55	4.28	3.53	2.87	4.28

December 31, 2024 calculation

Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $9,675,900K ÷ ($7,456,800K – $5,528,800K)
= 5.02

Based on the data provided for Biogen Inc, the working capital turnover has fluctuated over the period from March 31, 2020, to December 31, 2024. The working capital turnover ratio measures how efficiently a company is utilizing its working capital to generate sales revenue.

The working capital turnover ratio for Biogen Inc ranged from a high of 6.84 on September 30, 2024, to a low of 1.38 on June 30, 2023. A higher turnover ratio indicates that the company is effectively managing its working capital to support its operations and generate revenue. Conversely, a lower turnover ratio may suggest inefficiencies in managing working capital.

Overall, the working capital turnover for Biogen Inc showed variations over the period, reflecting changes in the company's ability to convert its working capital into sales. It is essential for investors and analysts to monitor this ratio to assess the company's efficiency in utilizing its working capital resources effectively.